Filter
693
Featured
87
179
Language
Document type
345
137
119
37
23
16
8
4
3
1
Countries
44
31
24
23
18
16
15
14
13
10
8
8
7
7
7
7
7
6
6
6
6
5
5
5
4
4
4
4
4
4
4
3
3
3
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
249
84
49
24
19
5
2
Toolboxes
123
85
55
37
32
31
26
17
13
9
7
7
5
4
2
1
1
1
1
1
EMCDDA Insights - 11
Accessed: 14.03.2019
Position Statement
Diabetes Care2018;42(Suppl. 1):S1–S194.
Introduction
Chapter A.7
Introduction
Chapter A.14
Mood disorders
Chapter E.1
2015 edition
Mood disorders
Chapter E.2
Mood disorders
Chapter E.3
2016 edition
Anxiety disorders
Chapter F.2
Anxiety disorders
Chapter F.3
Anxiety disorders
Chapter F.5
Other disorders Chapter H.1
Other disorders
Chapter H.3
Other disorders
Chapter H.5
Miscellaneous
Child and adolescent psychiatric emergencies
Chapter J.1
Miscellaneous
Chapter J.5
Externalizing disorders
Chapter D.1
Attention deficit hyperactivity disorder
Alcohol misuses
Substance use disorders
Chapter G.1
Q15. SCOPING QUESTION: Is pharmacological intervention effective and safe for treatment of psychotic disorders in adolescents (including schizophrenia and bipolar disorder)?
